Abecma, Breyanzi, CARVYKTI, Kimiya, Tecartus, Yakarta
CAR T Kwayoyin Farfadowar Kwayoyin Halittar Dan Adam: Nasara da Kalubale
Gabatarwa A cikin ilimin cututtukan daji, immunotherapy ya fito azaman hanyar majagaba, yin amfani da tsarin garkuwar jiki don yaƙar cutar sankarau. Akwai hanyoyin rigakafi da yawa, amma Chimeric Antigen Rece.
Breyanzi, Juno Therapeutics, Babban lymphoma B-cell, Farashin LBCL, fasalin
Lisocabtagene maraleucel an amince da shi ta FDA don maganin layi na biyu na babban lymphoma B-cell
Yuli 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) an amince da shi ta Cibiyar Abinci da Magunguna don manya marasa lafiya tare da babban lymphoma B-cell (LBCL) waɗanda ke da cututtukan da ba su da ƙarfi zuwa chemoi na farko.
BMS, Breyanzi, Mota-T Ciwon ƙwayar cuta, T-Cell CAR, CART far, USFDA
Breyanzi - Sabon C-T-Cell far daga BMS
Yuli 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), wani labari CD19-directed chimeric antigen receptor (CAR) T cell magani wanda Bristol Myers Squibb (BMS) ya haɓaka, Hukumar Abinci da Magunguna ta Amurka (US.